Table 1.
Details of recipients and diagnostic indications (n = 182)
| n (%) | |
| Female | 25 (13.74) |
| Male | 157 (86.26) |
| Age (yr) | |
| 18-60 | 173 (95.05) |
| 60-69 | 9 (4.95) |
| Diagnostic indications | |
| Liver cirrhosis | 74 (40.66) |
| Hepatitis B | 52 (28.57) |
| Hepatitis C | 5 (2.75) |
| Cholestasis | 5 (2.75) |
| Alcoholic | 4 (2.20) |
| Others | 8 (4.39) |
| Hepatic carcinoma | 77 (42.31) |
| FIF | 10 (5.49) |
| Acute-on-chronic hepatic failure | 9 (4.94) |
| Budd-Chiari[19] | 4 (2.20) |
| DI IBS | 4 (2.20) |
| Post-trauma hepatic failure | 1 (0.55) |
| Hepatic echinococcosis | 2 (1.10) |
| Polycystic liver | 1 (0.55) |
| MELD | |
| 1-13 | 86 (47.25) |
| 14-24 | 63 (34.62) |
| ≥ 25 | 33 (18.13) |
FIF: Fulminant liver failure; DI IBS: Diffuse ischemic intrahepatic biliary stenosis; MELD: Model for end-stage liver disease.